Standardizing the Amyloid Frontier: Inside FDA Clearance of MICSI-PET
Dr. Dereck Mush, MD, MBA
Profound Medical
Provides customized, incision-free therapeutic platforms utilizing real-time MRI-guided ultrasound ablation.
What they do
Profound Medical designs medical devices that combine real-time MRI imaging with thermal ultrasound therapy. Its platforms deliver precise, incision-free ablation of diseased prostate tissues, allowing urologists to treat prostate cancer while minimizing side effects and recovery times.
The record
- Vertical
- Diagnostics & Imaging
- Sub-segment
- MRI-guided therapies
- Product type
- Device
- Stage
- Public
- Headquarters
- Mississauga, Canada
- Region
- North America
- Founded
- 2008
- Total funding
- $120M raised
Notable investors: Genesys Capital, BDC Venture Capital.
Also in Diagnostics & Imaging
Related on The Signal
Dr. Dereck Mush, MD, MBA
The Radiopharmaceutical Infrastructure Playbook: Why Telix's FDA Approval for Pixclara Redefines Neuro-Oncology Diagnostics and Theranostics
Dr. Dereck Mush, MD, MBA
Inside SimBioSys TumorSight Risk: Bringing Recurrence Assessment Into the MRI Workflow
Dr. Dereck Mush, MD, MBA
Synthetic CT and Radiation-Free Orthopedics: The Economics of Single-Modality MRI Surgical Workflows
Dr. Dereck Mush, MD, MBA